Form 4 for NVCR NovoCure Ltd
Accepted 2024-06-06 00:00:00 ET · period of report 2024-06-05 · accession 0001562180-24-004774 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-06 | 2024-06-05 | NVCR | Madden Martin J. | Dir | A - Grant | $0.00 | +4,053 | 19.7K | +26% | $0 |
| D | 2024-06-06 | 2024-06-05 | NVCR | Madden Martin J. | Dir | A - Grant | $0.00 | +6,229 | 6,229 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-06-05 | A | A | 4,053 | $0.00 | 19,673 | D | — | — | (F1) These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders. (F2) Report no longer includes indirect ownership of shares held by filer's adult child. Child no longer shares a residence with the filer. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-05 | A | A | 6,229 | $0.00 | 6,229 | D | $23.13 · — to 2034-06-04 | 6,229 Ordinary Shares | (F3) Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders. |